KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Goodwill (2016 - 2025)

Boston Scientific's Goodwill history spans 16 years, with the latest figure at $18.3 billion for Q4 2025.

  • For Q4 2025, Goodwill rose 6.98% year-over-year to $18.3 billion; the TTM value through Dec 2025 reached $18.3 billion, up 6.98%, while the annual FY2025 figure was $18.3 billion, 6.98% up from the prior year.
  • Goodwill for Q4 2025 was $18.3 billion at Boston Scientific, up from $17.1 billion in the prior quarter.
  • Across five years, Goodwill topped out at $18.3 billion in Q4 2025 and bottomed at $11.8 billion in Q3 2021.
  • The 5-year median for Goodwill is $12.9 billion (2022), against an average of $14.1 billion.
  • The largest annual shift saw Goodwill increased 20.47% in 2021 before it increased 6.98% in 2025.
  • A 5-year view of Goodwill shows it stood at $12.0 billion in 2021, then rose by 7.77% to $12.9 billion in 2022, then rose by 5.33% to $13.6 billion in 2023, then grew by 25.58% to $17.1 billion in 2024, then rose by 6.98% to $18.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Goodwill are $18.3 billion (Q4 2025), $17.1 billion (Q4 2024), and $13.6 billion (Q3 2023).